Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02081144Phase 1Completed
Phase 1, randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by Yale University. Primary endpoint: Survey of satisfaction and usage of Smokefree TXT Program at 1 month. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02081144.